[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.121.0. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1992

Phosphomonoesters and Phosphodiesters in the Brains of Schizophrenic Patients-Reply

Author Affiliations

University of Pittsburgh 130 DeSoto St, Room A736 Crabtree Hall/GSPH Pittsburgh, PA 15261
Pittsburgh, Pa

Arch Gen Psychiatry. 1992;49(5):417. doi:10.1001/archpsyc.1992.01820050081017
Abstract

In Reply. —  Brown raises a very in- teresting point; that is, do the brain PME and PDE levels in schizophrenic patients correlate with the clinical subtype? In our preliminary report,1 there were five paranoid and six undifferentiated schizophrenic patients.There were no significant differences in PME and PDE levels (mean± SD) among the control(PME, 20.25±2.97 mol %; PDE, 32.20±1.96. mol %), paranoid (PME, 14.77±2.28 mol %; PDE,38.52±5,58 mol %), and undifferentiated (PME, 16.05±3.49 mol %; PDE, 34.70±4.06 mol %) schizophrenic patients in this small sample, although the PDE levels were higher and PME levels lower in the paranoid patients. Perhaps with a larger sample, a difference between paranoid and undifferentiated patients will be observed.A more likely explanation for the difference between the PME and PDE findings in our preliminary study and those reported by Williamson et al2 is that our patients were "first-break, never-medicated" and those studied by Williamson et al were patients

First Page Preview View Large
First page PDF preview
First page PDF preview
×